Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1979 1
1982 1
1983 1
1984 1
1990 2
1992 3
1993 1
1994 2
1996 4
1997 1
1998 2
1999 4
2000 15
2001 9
2002 16
2003 9
2004 9
2005 14
2006 6
2007 9
2008 15
2009 6
2010 15
2011 19
2012 18
2013 21
2014 23
2015 23
2016 22
2017 18
2018 30
2019 28
2020 18
2021 28
2022 28
2023 26
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

414 results

Results by year

Filters applied: . Clear all
Page 1
Antibodies against endogenous retroviruses promote lung cancer immunotherapy.
Ng KW, Boumelha J, Enfield KSS, Almagro J, Cha H, Pich O, Karasaki T, Moore DA, Salgado R, Sivakumar M, Young G, Molina-Arcas M, de Carné Trécesson S, Anastasiou P, Fendler A, Au L, Shepherd STC, Martínez-Ruiz C, Puttick C, Black JRM, Watkins TBK, Kim H, Shim S, Faulkner N, Attig J, Veeriah S, Magno N, Ward S, Frankell AM, Al Bakir M, Lim EL, Hill MS, Wilson GA, Cook DE, Birkbak NJ, Behrens A, Yousaf N, Popat S, Hackshaw A; TRACERx Consortium; CAPTURE Consortium; Hiley CT, Litchfield K, McGranahan N, Jamal-Hanjani M, Larkin J, Lee SH, Turajlic S, Swanton C, Downward J, Kassiotis G. Ng KW, et al. Among authors: behrens a. Nature. 2023 Apr;616(7957):563-573. doi: 10.1038/s41586-023-05771-9. Epub 2023 Apr 12. Nature. 2023. PMID: 37046094 Free PMC article.
USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer.
Nelson JK, Thin MZ, Evan T, Howell S, Wu M, Almeida B, Legrave N, Koenis DS, Koifman G, Sugimoto Y, Llorian Sopena M, MacRae J, Nye E, Howell M, Snijders AP, Prachalias A, Zen Y, Sarker D, Behrens A. Nelson JK, et al. Among authors: behrens a. Nat Commun. 2022 Apr 19;13(1):2070. doi: 10.1038/s41467-022-29684-9. Nat Commun. 2022. PMID: 35440539 Free PMC article.
Antigen retrieval and clearing for whole-organ immunofluorescence by FLASH.
Messal HA, Almagro J, Zaw Thin M, Tedeschi A, Ciccarelli A, Blackie L, Anderson KI, Miguel-Aliaga I, van Rheenen J, Behrens A. Messal HA, et al. Among authors: behrens a. Nat Protoc. 2021 Jan;16(1):239-262. doi: 10.1038/s41596-020-00414-z. Epub 2020 Nov 27. Nat Protoc. 2021. PMID: 33247285
GREM1 is required to maintain cellular heterogeneity in pancreatic cancer.
Lan L, Evan T, Li H, Hussain A, Ruiz EJ, Zaw Thin M, Ferreira RMM, Ps H, Riising EM, Zen Y, Almagro J, Ng KW, Soro-Barrio P, Nelson J, Koifman G, Carvalho J, Nye EL, He Y, Zhang C, Sadanandam A, Behrens A. Lan L, et al. Among authors: behrens a. Nature. 2022 Jul;607(7917):163-168. doi: 10.1038/s41586-022-04888-7. Epub 2022 Jun 29. Nature. 2022. PMID: 35768509
Ocular Emergencies: Red Eye.
Tarff A, Behrens A. Tarff A, et al. Among authors: behrens a. Med Clin North Am. 2017 May;101(3):615-639. doi: 10.1016/j.mcna.2016.12.013. Epub 2017 Mar 8. Med Clin North Am. 2017. PMID: 28372717 Review.
Tissue architecture in tumor initiation and progression.
Almagro J, Messal HA, Elosegui-Artola A, van Rheenen J, Behrens A. Almagro J, et al. Among authors: behrens a. Trends Cancer. 2022 Jun;8(6):494-505. doi: 10.1016/j.trecan.2022.02.007. Epub 2022 Mar 15. Trends Cancer. 2022. PMID: 35300951 Free article. Review.
Corneal topography.
Seitz B, Behrens A, Langenbucher A. Seitz B, et al. Among authors: behrens a. Curr Opin Ophthalmol. 1997 Aug;8(4):8-24. doi: 10.1097/00055735-199708000-00003. Curr Opin Ophthalmol. 1997. PMID: 10170448 Review.
414 results